Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report.
For further information please contact: ThromboGenics Wouter Piepers, Global Head of Corporate Communications Tel: +32-16-75-13-10 / +32(0)478-33-56-32 email@example.com Dr. Patrik De Haes, CEO Tel: +32-16-75-13-10 firstname.lastname@example.org Chris Buyse, CFO Tel: +32-16-75-13-10 email@example.com
Citigate Dewe Rogerson David Dible/ Nina Enegren/ Sita Shah Tel: +44 20-7638-9571 firstname.lastname@example.org
The Trout Group Todd James/ Simon Harnest Tel: +1-646-378-2926 email@example.comSOURCE ThromboGenics NV
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts